Dihydronarwedine
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for accurate information.
Dihydronarwedine Product Information
Dihydronarwedine is listed under Metabolite and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Galantamine. The product is supplied by Clearsynth under CAT No. CS-O-11259.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Dihydronarwedine
CAS No.
21041-10-1
CAT No.
CS-O-11259
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C17H21NO3
Molecular Weight
287.35
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for accurate information.
Description
Regulatory Description
Dihydronarwedine is supplied with detailed characterization data compliant with regulatory guideline. Dihydronarwedine can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Galantamine.
Overview
"Dihydronarwedine is a metabolite of Galanthamine , a selective acetylcholinesterase inhibitor and therapeutic agent for the treatment and prevention of Alzheimer’s disease and disorders resulting from reduced neuronal metabolism."
Synonyms
Dihydronarwedine
Application Notes
"Dihydronarwedine is a metabolite of Galanthamine , a selective acetylcholinesterase inhibitor and therapeutic agent for the treatment and prevention of Alzheimer’s disease and disorders resulting from reduced neuronal metabolism."
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.